China In Vitro Toxicity Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 In Vitro Toxicity Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China In Vitro Toxicity Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China In Vitro Toxicity Overall Market Size
2.1 China In Vitro Toxicity Market Size: 2021 VS 2027
2.2 China In Vitro Toxicity Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In Vitro Toxicity Players in China Market
3.2 Top China In Vitro Toxicity Companies Ranked by Revenue
3.3 China In Vitro Toxicity Revenue by Companies
3.4 Top 3 and Top 5 In Vitro Toxicity Companies in China Market, by Revenue in 2020
3.5 Companies In Vitro Toxicity Product Type
3.6 Tier 1, Tier 2 and Tier 3 In Vitro Toxicity Players in China Market
3.6.1 List of Tier 1 In Vitro Toxicity Companies in China
3.6.2 List of Tier 2 and Tier 3 In Vitro Toxicity Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China In Vitro Toxicity Market Size Markets, 2021 & 2027
4.1.2 Dose Response
4.1.3 Threshold Response
4.2 By Type - China In Vitro Toxicity Revenue & Forecasts
4.2.1 By Type - China In Vitro Toxicity Revenue, 2016-2021
4.2.2 By Type - China In Vitro Toxicity Revenue, 2022-2027
4.2.3 By Type - China In Vitro Toxicity Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China In Vitro Toxicity Market Size, 2021 & 2027
5.1.2 Distribution
5.1.3 Excretion
5.1.4 Metabolism
5.2 By Application - China In Vitro Toxicity Revenue & Forecasts
5.2.1 By Application - China In Vitro Toxicity Revenue, 2016-2021
5.2.2 By Application - China In Vitro Toxicity Revenue, 2022-2027
5.2.3 By Application - China In Vitro Toxicity Revenue Market Share, 2016-2027
6 In Vitro Toxicity Companies Profiles
6.1 Agilent Technologies
6.1.1 Agilent Technologies Company Details
6.1.2 Agilent Technologies Business Overview
6.1.3 Agilent Technologies In Vitro Toxicity Introduction
6.1.4 Agilent Technologies In Vitro Toxicity Revenue in China Market (2016-2021)
6.1.5 Agilent Technologies Recent Developments
6.2 Covance
6.2.1 Covance Company Details
6.2.2 Covance Business Overview
6.2.3 Covance In Vitro Toxicity Introduction
6.2.4 Covance In Vitro Toxicity Revenue in China Market (2016-2021)
6.2.5 Covance Recent Developments
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Company Details
6.3.2 Bio-Rad Laboratories Business Overview
6.3.3 Bio-Rad Laboratories In Vitro Toxicity Introduction
6.3.4 Bio-Rad Laboratories In Vitro Toxicity Revenue in China Market (2016-2021)
6.3.5 Bio-Rad Laboratories Recent Developments
6.4 General Electric
6.4.1 General Electric Company Details
6.4.2 General Electric Business Overview
6.4.3 General Electric In Vitro Toxicity Introduction
6.4.4 General Electric In Vitro Toxicity Revenue in China Market (2016-2021)
6.4.5 General Electric Recent Developments
6.5 Eurofins Scientific
6.5.1 Eurofins Scientific Company Details
6.5.2 Eurofins Scientific Business Overview
6.5.3 Eurofins Scientific In Vitro Toxicity Introduction
6.5.4 Eurofins Scientific In Vitro Toxicity Revenue in China Market (2016-2021)
6.5.5 Eurofins Scientific Recent Developments
6.6 BioReliance
6.6.1 BioReliance Company Details
6.6.2 BioReliance Business Overview
6.6.3 BioReliance In Vitro Toxicity Introduction
6.6.4 BioReliance In Vitro Toxicity Revenue in China Market (2016-2021)
6.6.5 BioReliance Recent Developments
6.7 Charles River Laboratories International
6.7.1 Charles River Laboratories International Company Details
6.7.2 Charles River Laboratories International Business Overview
6.7.3 Charles River Laboratories International In Vitro Toxicity Introduction
6.7.4 Charles River Laboratories International In Vitro Toxicity Revenue in China Market (2016-2021)
6.7.5 Charles River Laboratories International Recent Developments
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Details
6.8.2 Thermo Fisher Scientific Business Overview
6.8.3 Thermo Fisher Scientific In Vitro Toxicity Introduction
6.8.4 Thermo Fisher Scientific In Vitro Toxicity Revenue in China Market (2016-2021)
6.8.5 Thermo Fisher Scientific Recent Developments
6.9 Catalent
6.9.1 Catalent Company Details
6.9.2 Catalent Business Overview
6.9.3 Catalent In Vitro Toxicity Introduction
6.9.4 Catalent In Vitro Toxicity Revenue in China Market (2016-2021)
6.9.5 Catalent Recent Developments
6.10 Cyprotex
6.10.1 Cyprotex Company Details
6.10.2 Cyprotex Business Overview
6.10.3 Cyprotex In Vitro Toxicity Introduction
6.10.4 Cyprotex In Vitro Toxicity Revenue in China Market (2016-2021)
6.10.5 Cyprotex Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. In Vitro Toxicity Market Opportunities & Trends in China Market
Table 2. In Vitro Toxicity Market Drivers in China Market
Table 3. In Vitro Toxicity Market Restraints in China Market
Table 4. Key Players of In Vitro Toxicity in China Market
Table 5. Top In Vitro Toxicity Players in China Market, Ranking by Revenue (2019)
Table 6. China In Vitro Toxicity Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China In Vitro Toxicity Revenue Share by Companies, 2016-2021
Table 8. Companies In Vitro Toxicity Product Type
Table 9. List of Tier 1 In Vitro Toxicity Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 In Vitro Toxicity Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China In Vitro Toxicity Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China In Vitro Toxicity Revenue (US$, Mn), 2016-2021
Table 13. By Type - China In Vitro Toxicity Revenue (US$, Mn), 2022-2027
Table 14. By Application - China In Vitro Toxicity Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China In Vitro Toxicity Revenue (US$, Mn), 2016-2021
Table 16. By Application - China In Vitro Toxicity Revenue (US$, Mn), 2022-2027
Table 17. Agilent Technologies Company Details
Table 18. Agilent Technologies Business Overview
Table 19. Agilent Technologies In Vitro Toxicity Product
Table 20. Agilent Technologies In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Agilent Technologies Recent Developments
Table 22. Covance Company Details
Table 23. Covance Business Overview
Table 24. Covance In Vitro Toxicity Product
Table 25. Covance In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Covance Recent Developments
Table 27. Bio-Rad Laboratories Company Details
Table 28. Bio-Rad Laboratories Business Overview
Table 29. Bio-Rad Laboratories In Vitro Toxicity Product
Table 30. Bio-Rad Laboratories In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Bio-Rad Laboratories Recent Developments
Table 32. General Electric Company Details
Table 33. General Electric Business Overview
Table 34. General Electric In Vitro Toxicity Product
Table 35. General Electric In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 36. General Electric Recent Developments
Table 37. Eurofins Scientific Company Details
Table 38. Eurofins Scientific Business Overview
Table 39. Eurofins Scientific In Vitro Toxicity Product
Table 40. Eurofins Scientific In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Eurofins Scientific Recent Developments
Table 42. BioReliance Company Details
Table 43. BioReliance Business Overview
Table 44. BioReliance In Vitro Toxicity Product
Table 45. BioReliance In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 46. BioReliance Recent Developments
Table 47. Charles River Laboratories International Company Details
Table 48. Charles River Laboratories International Business Overview
Table 49. Charles River Laboratories International In Vitro Toxicity Product
Table 50. Charles River Laboratories International In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Charles River Laboratories International Recent Developments
Table 52. Thermo Fisher Scientific Company Details
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific In Vitro Toxicity Product
Table 55. Thermo Fisher Scientific In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Developments
Table 57. Catalent Company Details
Table 58. Catalent Business Overview
Table 59. Catalent In Vitro Toxicity Product
Table 60. Catalent In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Catalent Recent Developments
Table 62. Cyprotex Company Details
Table 63. Cyprotex Business Overview
Table 64. Cyprotex In Vitro Toxicity Product
Table 65. Cyprotex In Vitro Toxicity Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Cyprotex Recent Developments
List of FiguresFigure 1. In Vitro Toxicity Segment by Type
Figure 2. In Vitro Toxicity Segment by Application
Figure 3. China In Vitro Toxicity Market Overview: 2020
Figure 4. China In Vitro Toxicity Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China In Vitro Toxicity Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by In Vitro Toxicity Revenue in 2020
Figure 7. By Type - China In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 8. By Application - China In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 9. Agilent Technologies In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Covance In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bio-Rad Laboratories In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. General Electric In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Eurofins Scientific In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. BioReliance In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Charles River Laboratories International In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Thermo Fisher Scientific In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Catalent In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Cyprotex In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)